4-(4-Chloro-1-methyl-1H-pyrazol-5-yl)-N-((3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl)furan-2-carboxamide

ID: ALA4529738

PubChem CID: 155545670

Max Phase: Preclinical

Molecular Formula: C20H19ClF2N4O2

Molecular Weight: 420.85

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1ncc(Cl)c1-c1coc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c1

Standard InChI:  InChI=1S/C20H19ClF2N4O2/c1-27-19(14(21)8-25-27)12-7-18(29-10-12)20(28)26-17-9-24-5-4-13(17)11-2-3-15(22)16(23)6-11/h2-3,6-8,10,13,17,24H,4-5,9H2,1H3,(H,26,28)/t13-,17+/m0/s1

Standard InChI Key:  XHJRBDCMLYCIII-SUMWQHHRSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   20.1560  -20.4215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1548  -21.2410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8629  -21.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5725  -21.2406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5697  -20.4179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8611  -20.0126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8593  -22.4645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1497  -22.8717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1475  -23.6853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8533  -24.0979    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5629  -23.6907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5668  -22.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4431  -22.4612    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7343  -22.8680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0276  -22.4575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7321  -23.6851    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9435  -21.6492    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1446  -21.4771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7341  -22.1838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2794  -22.7925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9212  -22.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3741  -21.6577    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6267  -21.9882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7100  -22.8012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5089  -22.9730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5456  -20.8587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8385  -23.7207    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   22.2759  -20.0066    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.8586  -19.1954    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7  3  1  6
  8 13  1  1
 13 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 15  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  2  0
 22 26  1  0
 25 27  1  0
  5 28  1  0
  6 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4529738

    ---

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.85Molecular Weight (Monoisotopic): 420.1165AlogP: 3.49#Rotatable Bonds: 4
Polar Surface Area: 72.09Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.20CX LogP: 2.59CX LogD: 0.80
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.68Np Likeness Score: -1.15

References

1. Dong X, Zhan W, Zhao M, Che J, Dai X, Wu Y, Xu L, Zhou Y, Zhao Y, Tian T, Cheng G, Jin Z, Li J, Shao Y, He Q, Yang B, Weng Q, Hu Y..  (2019)  Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design.,  62  (15): [PMID:31298542] [10.1021/acs.jmedchem.9b00891]

Source